Mitigating Uncertainty: A Roadmap to the Current Clinical Trial Environment
Sponsors and CROs alike need to give due consideration to the numerous time-sensitive aspects. A panel of seasoned experts will provide an overview of the current clinical trial environment in Europe, both EU and non-EU, and shed light on what is needed to ensure compliant trials, patients and medicines supply at a critical time.
- Study launch during COVID — mitigating uncertainty
- Engaging proactive CROs with the regulatory and clinical, data and supply chain management knowledge in the region sponsors may lack
- Transparency in communication and data to make critical decisions
Dr Nermeen Varawalla Chief Medical Officer & Head of Clinical Development at Atlantic Healthcare
Dr Yuri Martina SVP Development at Grünenthal
Roman Hrynchuk Chief Operating Officer at SanaClis